Follow
Ushashi Banerjee
Ushashi Banerjee
Dana Farber Cancer Institute/ Harvard Medical School
Verified email at dfci.harvard.edu
Title
Cited by
Cited by
Year
VB10, a new blood biomarker for differential diagnosis and recovery monitoring of acute viral and bacterial infections
S Ravichandran, U Banerjee, GD DR, R Kandukuru, C Thakur, ...
EBioMedicine 67, 2021
172021
A multi-pronged computational pipeline for prioritizing drug target strategies for latent tuberculosis
U Banerjee, S Sankar, A Singh, N Chandra
Frontiers in chemistry 8, 593497, 2020
122020
A 9-gene biomarker panel identifies bacterial coinfections in culture-negative COVID-19 cases
U Banerjee, P Rao, M Reddy, M Hussain, S Chunchanur, R Ambica, ...
Molecular omics 18, 814-820, 2022
102022
Immune subtyping in latent tuberculosis
U Banerjee, P Baloni, A Singh, N Chandra
Frontiers in immunology 12, 595746, 2021
102021
Systems-level profiling of early peripheral host-response landscape variations across COVID-19 severity states in an Indian cohort
U Banerjee, S Chunchanur, KN Balaji, A Singh, D Chakravortty, ...
Genes & Immunity 24 (4), 183-193, 2023
42023
Cysteine desulfurase (IscS)–mediated fine-tuning of bioenergetics and SUF expression prevents Mycobacterium tuberculosis hypervirulence
M Das, S Sreedharan, S Shee, N Malhotra, M Nandy, U Banerjee, S Kohli, ...
Science Advances 9 (50), eadh2858, 2023
12023
The MYCN 5′ UTR as a therapeutic target in neuroblastoma
MP Volegova, LE Brown, U Banerjee, R Dries, B Sharma, A Kennedy, ...
Cell Reports 43 (5), 2024
2024
Inhibition of leukotriene‐B4 signalling‐mediated host response to tuberculosis is a potential mode of adjunctive host‐directed therapy
U Banerjee, SM Borbora, M Guha, V Yadav, V Sanjay, A Singh, KN Balaji, ...
Immunology, 2024
2024
PathTracer Comprehensively Identifies Hypoxia-Induced Dormancy Adaptations in Mycobacterium tuberculosis
U Banerjee, A Chedere, R Padaki, A Mohan, N Sambaturu, A Singh, ...
Journal of Chemical Information and Modeling 63 (19), 6156-6167, 2023
2023
Pressured cytotoxic T cell epitope strength among SARS-CoV-2 variants correlates with COVID-19 severity.
V Rao, U Banerjee, N Sambaturu, S Chunchanur, R Ambica, N Chandra
HLA, 2023
2023
A systems-level exploration of host responses across the disease spectrum of Tuberculosis and COVID-19
U Banerjee
2022
The system can't perform the operation now. Try again later.
Articles 1–11